nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—Topotecan—Irinotecan—colon cancer	0.0278	0.714	CbGdCrCtD
Dexrazoxane—TOP2B—embryo—colon cancer	0.0216	0.147	CbGeAlD
Dexrazoxane—TOP2B—smooth muscle tissue—colon cancer	0.017	0.115	CbGeAlD
Dexrazoxane—TOP2B—renal system—colon cancer	0.0164	0.111	CbGeAlD
Dexrazoxane—TOP2B—lymphoid tissue—colon cancer	0.0136	0.0922	CbGeAlD
Dexrazoxane—TOP2B—digestive system—colon cancer	0.0134	0.0911	CbGeAlD
Dexrazoxane—TOP2B—bone marrow—colon cancer	0.0124	0.084	CbGeAlD
Dexrazoxane—TOP2B—vagina—colon cancer	0.0119	0.0805	CbGeAlD
Dexrazoxane—TOP2B—liver—colon cancer	0.01	0.0679	CbGeAlD
Dexrazoxane—TOP2A—bone marrow—colon cancer	0.00911	0.0618	CbGeAlD
Dexrazoxane—TOP2A—vagina—colon cancer	0.00873	0.0592	CbGeAlD
Dexrazoxane—TOP2B—lymph node—colon cancer	0.00768	0.052	CbGeAlD
Dexrazoxane—TOP2A—lymph node—colon cancer	0.00564	0.0383	CbGeAlD
Dexrazoxane—Haemoglobin decreased—Capecitabine—colon cancer	0.00548	0.00674	CcSEcCtD
Dexrazoxane—Hypercalcaemia—Capecitabine—colon cancer	0.00543	0.00668	CcSEcCtD
Dexrazoxane—Vaginal haemorrhage—Capecitabine—colon cancer	0.0051	0.00627	CcSEcCtD
Dexrazoxane—Oesophagitis—Fluorouracil—colon cancer	0.00493	0.00606	CcSEcCtD
Dexrazoxane—Sepsis—Irinotecan—colon cancer	0.00489	0.00601	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.0047	0.00578	CcSEcCtD
Dexrazoxane—Sepsis—Fluorouracil—colon cancer	0.00468	0.00576	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Methotrexate—colon cancer	0.00467	0.00574	CcSEcCtD
Dexrazoxane—Injection site pain—Capecitabine—colon cancer	0.00462	0.00568	CcSEcCtD
Dexrazoxane—TOP2A—Topotecan—Irinotecan—colon cancer	0.0045	0.115	CbGdCrCtD
Dexrazoxane—Hyponatraemia—Vincristine—colon cancer	0.00422	0.00519	CcSEcCtD
Dexrazoxane—Hyponatraemia—Irinotecan—colon cancer	0.00411	0.00505	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Capecitabine—colon cancer	0.00399	0.0049	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Irinotecan—colon cancer	0.00383	0.00471	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00378	0.00465	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00377	0.00464	CcSEcCtD
Dexrazoxane—Injection site reaction—Capecitabine—colon cancer	0.00375	0.00461	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00368	0.00453	CcSEcCtD
Dexrazoxane—Pancytopenia—Vincristine—colon cancer	0.00345	0.00424	CcSEcCtD
Dexrazoxane—Oesophagitis—Capecitabine—colon cancer	0.00345	0.00424	CcSEcCtD
Dexrazoxane—Neutropenia—Vincristine—colon cancer	0.0034	0.00417	CcSEcCtD
Dexrazoxane—Dysphagia—Fluorouracil—colon cancer	0.00339	0.00416	CcSEcCtD
Dexrazoxane—Neutropenia—Irinotecan—colon cancer	0.00331	0.00407	CcSEcCtD
Dexrazoxane—Weight decreased—Vincristine—colon cancer	0.00329	0.00404	CcSEcCtD
Dexrazoxane—Sepsis—Capecitabine—colon cancer	0.00327	0.00402	CcSEcCtD
Dexrazoxane—Pneumonia—Vincristine—colon cancer	0.00326	0.004	CcSEcCtD
Dexrazoxane—Depression—Vincristine—colon cancer	0.00323	0.00397	CcSEcCtD
Dexrazoxane—Extravasation—Methotrexate—colon cancer	0.00322	0.00396	CcSEcCtD
Dexrazoxane—Pancytopenia—Fluorouracil—colon cancer	0.00322	0.00395	CcSEcCtD
Dexrazoxane—TOP2A—Vindesine—Vincristine—colon cancer	0.00322	0.0825	CbGdCrCtD
Dexrazoxane—Weight decreased—Irinotecan—colon cancer	0.0032	0.00393	CcSEcCtD
Dexrazoxane—Phlebitis—Capecitabine—colon cancer	0.00318	0.00391	CcSEcCtD
Dexrazoxane—Pneumonia—Irinotecan—colon cancer	0.00317	0.0039	CcSEcCtD
Dexrazoxane—Stomatitis—Vincristine—colon cancer	0.00316	0.00388	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00315	0.00387	CcSEcCtD
Dexrazoxane—Stomatitis—Irinotecan—colon cancer	0.00307	0.00378	CcSEcCtD
Dexrazoxane—Pneumonia—Fluorouracil—colon cancer	0.00304	0.00373	CcSEcCtD
Dexrazoxane—Infestation NOS—Fluorouracil—colon cancer	0.00302	0.00371	CcSEcCtD
Dexrazoxane—Infestation—Fluorouracil—colon cancer	0.00302	0.00371	CcSEcCtD
Dexrazoxane—Stomatitis—Fluorouracil—colon cancer	0.00294	0.00362	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Vincristine—colon cancer	0.00286	0.00351	CcSEcCtD
Dexrazoxane—Haemoglobin—Irinotecan—colon cancer	0.00285	0.0035	CcSEcCtD
Dexrazoxane—Haemorrhage—Irinotecan—colon cancer	0.00283	0.00348	CcSEcCtD
Dexrazoxane—Agranulocytosis—Fluorouracil—colon cancer	0.00282	0.00346	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Irinotecan—colon cancer	0.00278	0.00342	CcSEcCtD
Dexrazoxane—Hyponatraemia—Capecitabine—colon cancer	0.00275	0.00338	CcSEcCtD
Dexrazoxane—Haemoglobin—Fluorouracil—colon cancer	0.00272	0.00335	CcSEcCtD
Dexrazoxane—Haemorrhage—Fluorouracil—colon cancer	0.00271	0.00333	CcSEcCtD
Dexrazoxane—Cardiac disorder—Vincristine—colon cancer	0.0027	0.00332	CcSEcCtD
Dexrazoxane—Angiopathy—Vincristine—colon cancer	0.00264	0.00324	CcSEcCtD
Dexrazoxane—Cardiac disorder—Irinotecan—colon cancer	0.00263	0.00323	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Vincristine—colon cancer	0.00262	0.00322	CcSEcCtD
Dexrazoxane—Alopecia—Vincristine—colon cancer	0.00257	0.00316	CcSEcCtD
Dexrazoxane—Angiopathy—Irinotecan—colon cancer	0.00257	0.00316	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Capecitabine—colon cancer	0.00257	0.00315	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Irinotecan—colon cancer	0.00255	0.00314	CcSEcCtD
Dexrazoxane—Mental disorder—Vincristine—colon cancer	0.00255	0.00313	CcSEcCtD
Dexrazoxane—Alopecia—Irinotecan—colon cancer	0.0025	0.00307	CcSEcCtD
Dexrazoxane—Breast disorder—Capecitabine—colon cancer	0.00247	0.00304	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00247	0.00303	CcSEcCtD
Dexrazoxane—Sepsis—Methotrexate—colon cancer	0.00244	0.003	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00242	0.00297	CcSEcCtD
Dexrazoxane—Alopecia—Fluorouracil—colon cancer	0.0024	0.00294	CcSEcCtD
Dexrazoxane—Dysphagia—Capecitabine—colon cancer	0.00237	0.00291	CcSEcCtD
Dexrazoxane—Erythema—Fluorouracil—colon cancer	0.00236	0.0029	CcSEcCtD
Dexrazoxane—Anaemia—Vincristine—colon cancer	0.00234	0.00287	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Irinotecan—colon cancer	0.00229	0.00281	CcSEcCtD
Dexrazoxane—Anaemia—Irinotecan—colon cancer	0.00228	0.0028	CcSEcCtD
Dexrazoxane—Leukopenia—Vincristine—colon cancer	0.00226	0.00278	CcSEcCtD
Dexrazoxane—Pancytopenia—Capecitabine—colon cancer	0.00225	0.00276	CcSEcCtD
Dexrazoxane—Malaise—Irinotecan—colon cancer	0.00222	0.00273	CcSEcCtD
Dexrazoxane—Neutropenia—Capecitabine—colon cancer	0.00221	0.00272	CcSEcCtD
Dexrazoxane—Syncope—Irinotecan—colon cancer	0.00221	0.00272	CcSEcCtD
Dexrazoxane—Leukopenia—Irinotecan—colon cancer	0.00221	0.00271	CcSEcCtD
Dexrazoxane—Anaemia—Fluorouracil—colon cancer	0.00218	0.00268	CcSEcCtD
Dexrazoxane—Loss of consciousness—Irinotecan—colon cancer	0.00217	0.00266	CcSEcCtD
Dexrazoxane—Myalgia—Vincristine—colon cancer	0.00215	0.00265	CcSEcCtD
Dexrazoxane—Cough—Irinotecan—colon cancer	0.00215	0.00264	CcSEcCtD
Dexrazoxane—Weight decreased—Capecitabine—colon cancer	0.00214	0.00263	CcSEcCtD
Dexrazoxane—Pneumonia—Capecitabine—colon cancer	0.00212	0.00261	CcSEcCtD
Dexrazoxane—Leukopenia—Fluorouracil—colon cancer	0.00211	0.0026	CcSEcCtD
Dexrazoxane—Infestation NOS—Capecitabine—colon cancer	0.00211	0.00259	CcSEcCtD
Dexrazoxane—Infestation—Capecitabine—colon cancer	0.00211	0.00259	CcSEcCtD
Dexrazoxane—Depression—Capecitabine—colon cancer	0.0021	0.00259	CcSEcCtD
Dexrazoxane—Discomfort—Irinotecan—colon cancer	0.00207	0.00255	CcSEcCtD
Dexrazoxane—Stomatitis—Capecitabine—colon cancer	0.00206	0.00253	CcSEcCtD
Dexrazoxane—Infection—Vincristine—colon cancer	0.00205	0.00252	CcSEcCtD
Dexrazoxane—TOP2A—Vinorelbine—Vincristine—colon cancer	0.00203	0.0521	CbGdCrCtD
Dexrazoxane—Nervous system disorder—Vincristine—colon cancer	0.00203	0.00249	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Vincristine—colon cancer	0.00202	0.00249	CcSEcCtD
Dexrazoxane—Myalgia—Fluorouracil—colon cancer	0.00201	0.00247	CcSEcCtD
Dexrazoxane—Infection—Irinotecan—colon cancer	0.002	0.00246	CcSEcCtD
Dexrazoxane—Discomfort—Fluorouracil—colon cancer	0.00199	0.00244	CcSEcCtD
Dexrazoxane—Shock—Irinotecan—colon cancer	0.00198	0.00243	CcSEcCtD
Dexrazoxane—Nervous system disorder—Irinotecan—colon cancer	0.00197	0.00242	CcSEcCtD
Dexrazoxane—Agranulocytosis—Capecitabine—colon cancer	0.00197	0.00242	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Irinotecan—colon cancer	0.00197	0.00242	CcSEcCtD
Dexrazoxane—Anorexia—Vincristine—colon cancer	0.00197	0.00242	CcSEcCtD
Dexrazoxane—Anorexia—Irinotecan—colon cancer	0.00192	0.00236	CcSEcCtD
Dexrazoxane—Infection—Fluorouracil—colon cancer	0.00191	0.00235	CcSEcCtD
Dexrazoxane—Haemoglobin—Capecitabine—colon cancer	0.0019	0.00234	CcSEcCtD
Dexrazoxane—Haemorrhage—Capecitabine—colon cancer	0.00189	0.00233	CcSEcCtD
Dexrazoxane—Nervous system disorder—Fluorouracil—colon cancer	0.00189	0.00232	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Fluorouracil—colon cancer	0.00189	0.00232	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vincristine—colon cancer	0.00188	0.00231	CcSEcCtD
Dexrazoxane—Insomnia—Vincristine—colon cancer	0.00187	0.0023	CcSEcCtD
Dexrazoxane—Oedema peripheral—Capecitabine—colon cancer	0.00187	0.00229	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Capecitabine—colon cancer	0.00186	0.00229	CcSEcCtD
Dexrazoxane—Breast disorder—Methotrexate—colon cancer	0.00184	0.00226	CcSEcCtD
Dexrazoxane—Anorexia—Fluorouracil—colon cancer	0.00184	0.00226	CcSEcCtD
Dexrazoxane—Insomnia—Irinotecan—colon cancer	0.00182	0.00224	CcSEcCtD
Dexrazoxane—Decreased appetite—Vincristine—colon cancer	0.0018	0.00221	CcSEcCtD
Dexrazoxane—Dyspnoea—Irinotecan—colon cancer	0.00179	0.0022	CcSEcCtD
Dexrazoxane—Somnolence—Irinotecan—colon cancer	0.00179	0.0022	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vincristine—colon cancer	0.00178	0.00219	CcSEcCtD
Dexrazoxane—Fatigue—Vincristine—colon cancer	0.00178	0.00219	CcSEcCtD
Dexrazoxane—Pain—Vincristine—colon cancer	0.00177	0.00217	CcSEcCtD
Dexrazoxane—Constipation—Vincristine—colon cancer	0.00177	0.00217	CcSEcCtD
Dexrazoxane—Cardiac disorder—Capecitabine—colon cancer	0.00176	0.00216	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00175	0.00216	CcSEcCtD
Dexrazoxane—Decreased appetite—Irinotecan—colon cancer	0.00175	0.00215	CcSEcCtD
Dexrazoxane—Insomnia—Fluorouracil—colon cancer	0.00174	0.00214	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Irinotecan—colon cancer	0.00174	0.00213	CcSEcCtD
Dexrazoxane—Fatigue—Irinotecan—colon cancer	0.00173	0.00213	CcSEcCtD
Dexrazoxane—Pain—Irinotecan—colon cancer	0.00172	0.00211	CcSEcCtD
Dexrazoxane—Constipation—Irinotecan—colon cancer	0.00172	0.00211	CcSEcCtD
Dexrazoxane—Angiopathy—Capecitabine—colon cancer	0.00172	0.00211	CcSEcCtD
Dexrazoxane—Dyspnoea—Fluorouracil—colon cancer	0.00172	0.00211	CcSEcCtD
Dexrazoxane—Somnolence—Fluorouracil—colon cancer	0.00171	0.0021	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Capecitabine—colon cancer	0.00171	0.0021	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vincristine—colon cancer	0.00169	0.00208	CcSEcCtD
Dexrazoxane—Decreased appetite—Fluorouracil—colon cancer	0.00167	0.00206	CcSEcCtD
Dexrazoxane—Alopecia—Capecitabine—colon cancer	0.00167	0.00206	CcSEcCtD
Dexrazoxane—Pancytopenia—Methotrexate—colon cancer	0.00167	0.00206	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00166	0.00204	CcSEcCtD
Dexrazoxane—Mental disorder—Capecitabine—colon cancer	0.00166	0.00204	CcSEcCtD
Dexrazoxane—Feeling abnormal—Irinotecan—colon cancer	0.00166	0.00204	CcSEcCtD
Dexrazoxane—Erythema—Capecitabine—colon cancer	0.00165	0.00203	CcSEcCtD
Dexrazoxane—Malnutrition—Capecitabine—colon cancer	0.00165	0.00203	CcSEcCtD
Dexrazoxane—Neutropenia—Methotrexate—colon cancer	0.00165	0.00203	CcSEcCtD
Dexrazoxane—Pain—Fluorouracil—colon cancer	0.00165	0.00202	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Irinotecan—colon cancer	0.00164	0.00202	CcSEcCtD
Dexrazoxane—Abdominal pain—Vincristine—colon cancer	0.00163	0.00201	CcSEcCtD
Dexrazoxane—Body temperature increased—Vincristine—colon cancer	0.00163	0.00201	CcSEcCtD
Dexrazoxane—Abdominal pain—Irinotecan—colon cancer	0.00159	0.00195	CcSEcCtD
Dexrazoxane—Body temperature increased—Irinotecan—colon cancer	0.00159	0.00195	CcSEcCtD
Dexrazoxane—Feeling abnormal—Fluorouracil—colon cancer	0.00159	0.00195	CcSEcCtD
Dexrazoxane—Pneumonia—Methotrexate—colon cancer	0.00158	0.00194	CcSEcCtD
Dexrazoxane—Infestation NOS—Methotrexate—colon cancer	0.00157	0.00193	CcSEcCtD
Dexrazoxane—Infestation—Methotrexate—colon cancer	0.00157	0.00193	CcSEcCtD
Dexrazoxane—Depression—Methotrexate—colon cancer	0.00157	0.00193	CcSEcCtD
Dexrazoxane—Tremor—Capecitabine—colon cancer	0.00155	0.0019	CcSEcCtD
Dexrazoxane—Stomatitis—Methotrexate—colon cancer	0.00153	0.00188	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Capecitabine—colon cancer	0.00153	0.00188	CcSEcCtD
Dexrazoxane—Urticaria—Fluorouracil—colon cancer	0.00153	0.00188	CcSEcCtD
Dexrazoxane—Anaemia—Capecitabine—colon cancer	0.00152	0.00187	CcSEcCtD
Dexrazoxane—Body temperature increased—Fluorouracil—colon cancer	0.00152	0.00187	CcSEcCtD
Dexrazoxane—Malaise—Capecitabine—colon cancer	0.00149	0.00183	CcSEcCtD
Dexrazoxane—Asthenia—Vincristine—colon cancer	0.00148	0.00182	CcSEcCtD
Dexrazoxane—Syncope—Capecitabine—colon cancer	0.00148	0.00182	CcSEcCtD
Dexrazoxane—Leukopenia—Capecitabine—colon cancer	0.00148	0.00181	CcSEcCtD
Dexrazoxane—Agranulocytosis—Methotrexate—colon cancer	0.00147	0.0018	CcSEcCtD
Dexrazoxane—Loss of consciousness—Capecitabine—colon cancer	0.00145	0.00178	CcSEcCtD
Dexrazoxane—Asthenia—Irinotecan—colon cancer	0.00144	0.00177	CcSEcCtD
Dexrazoxane—Cough—Capecitabine—colon cancer	0.00144	0.00177	CcSEcCtD
Dexrazoxane—Haemoglobin—Methotrexate—colon cancer	0.00142	0.00174	CcSEcCtD
Dexrazoxane—Diarrhoea—Vincristine—colon cancer	0.00141	0.00174	CcSEcCtD
Dexrazoxane—Haemorrhage—Methotrexate—colon cancer	0.00141	0.00173	CcSEcCtD
Dexrazoxane—Myalgia—Capecitabine—colon cancer	0.0014	0.00173	CcSEcCtD
Dexrazoxane—TOP2A—Vinblastine—Vincristine—colon cancer	0.0014	0.0358	CbGdCrCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00139	0.00171	CcSEcCtD
Dexrazoxane—Discomfort—Capecitabine—colon cancer	0.00139	0.00171	CcSEcCtD
Dexrazoxane—Diarrhoea—Irinotecan—colon cancer	0.00138	0.00169	CcSEcCtD
Dexrazoxane—Dry mouth—Capecitabine—colon cancer	0.00137	0.00169	CcSEcCtD
Dexrazoxane—Dizziness—Vincristine—colon cancer	0.00137	0.00168	CcSEcCtD
Dexrazoxane—Pruritus—Fluorouracil—colon cancer	0.00136	0.00168	CcSEcCtD
Dexrazoxane—Infection—Capecitabine—colon cancer	0.00134	0.00164	CcSEcCtD
Dexrazoxane—Dizziness—Irinotecan—colon cancer	0.00133	0.00163	CcSEcCtD
Dexrazoxane—Shock—Capecitabine—colon cancer	0.00132	0.00163	CcSEcCtD
Dexrazoxane—Nervous system disorder—Capecitabine—colon cancer	0.00132	0.00162	CcSEcCtD
Dexrazoxane—Diarrhoea—Fluorouracil—colon cancer	0.00132	0.00162	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Capecitabine—colon cancer	0.00132	0.00162	CcSEcCtD
Dexrazoxane—Vomiting—Vincristine—colon cancer	0.00131	0.00161	CcSEcCtD
Dexrazoxane—Cardiac disorder—Methotrexate—colon cancer	0.00131	0.00161	CcSEcCtD
Dexrazoxane—Skin disorder—Capecitabine—colon cancer	0.00131	0.00161	CcSEcCtD
Dexrazoxane—Headache—Vincristine—colon cancer	0.00129	0.00159	CcSEcCtD
Dexrazoxane—Anorexia—Capecitabine—colon cancer	0.00128	0.00158	CcSEcCtD
Dexrazoxane—Angiopathy—Methotrexate—colon cancer	0.00128	0.00157	CcSEcCtD
Dexrazoxane—Vomiting—Irinotecan—colon cancer	0.00128	0.00157	CcSEcCtD
Dexrazoxane—Dizziness—Fluorouracil—colon cancer	0.00127	0.00157	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Methotrexate—colon cancer	0.00127	0.00156	CcSEcCtD
Dexrazoxane—Headache—Irinotecan—colon cancer	0.00126	0.00155	CcSEcCtD
Dexrazoxane—Alopecia—Methotrexate—colon cancer	0.00125	0.00153	CcSEcCtD
Dexrazoxane—Mental disorder—Methotrexate—colon cancer	0.00124	0.00152	CcSEcCtD
Dexrazoxane—Malnutrition—Methotrexate—colon cancer	0.00123	0.00151	CcSEcCtD
Dexrazoxane—Erythema—Methotrexate—colon cancer	0.00123	0.00151	CcSEcCtD
Dexrazoxane—Nausea—Vincristine—colon cancer	0.00123	0.00151	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00123	0.00151	CcSEcCtD
Dexrazoxane—Vomiting—Fluorouracil—colon cancer	0.00122	0.00151	CcSEcCtD
Dexrazoxane—Insomnia—Capecitabine—colon cancer	0.00122	0.0015	CcSEcCtD
Dexrazoxane—Headache—Fluorouracil—colon cancer	0.00121	0.00148	CcSEcCtD
Dexrazoxane—Dyspnoea—Capecitabine—colon cancer	0.0012	0.00148	CcSEcCtD
Dexrazoxane—Nausea—Irinotecan—colon cancer	0.00119	0.00147	CcSEcCtD
Dexrazoxane—Decreased appetite—Capecitabine—colon cancer	0.00117	0.00144	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Capecitabine—colon cancer	0.00116	0.00143	CcSEcCtD
Dexrazoxane—Fatigue—Capecitabine—colon cancer	0.00116	0.00143	CcSEcCtD
Dexrazoxane—Constipation—Capecitabine—colon cancer	0.00115	0.00141	CcSEcCtD
Dexrazoxane—Pain—Capecitabine—colon cancer	0.00115	0.00141	CcSEcCtD
Dexrazoxane—Nausea—Fluorouracil—colon cancer	0.00114	0.00141	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Methotrexate—colon cancer	0.00114	0.0014	CcSEcCtD
Dexrazoxane—Anaemia—Methotrexate—colon cancer	0.00113	0.00139	CcSEcCtD
Dexrazoxane—Feeling abnormal—Capecitabine—colon cancer	0.00111	0.00136	CcSEcCtD
Dexrazoxane—Malaise—Methotrexate—colon cancer	0.00111	0.00136	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Capecitabine—colon cancer	0.0011	0.00135	CcSEcCtD
Dexrazoxane—Leukopenia—Methotrexate—colon cancer	0.0011	0.00135	CcSEcCtD
Dexrazoxane—Cough—Methotrexate—colon cancer	0.00107	0.00132	CcSEcCtD
Dexrazoxane—Urticaria—Capecitabine—colon cancer	0.00107	0.00131	CcSEcCtD
Dexrazoxane—Abdominal pain—Capecitabine—colon cancer	0.00106	0.00131	CcSEcCtD
Dexrazoxane—Body temperature increased—Capecitabine—colon cancer	0.00106	0.00131	CcSEcCtD
Dexrazoxane—Myalgia—Methotrexate—colon cancer	0.00105	0.00128	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00104	0.00128	CcSEcCtD
Dexrazoxane—Discomfort—Methotrexate—colon cancer	0.00103	0.00127	CcSEcCtD
Dexrazoxane—Infection—Methotrexate—colon cancer	0.000995	0.00122	CcSEcCtD
Dexrazoxane—Nervous system disorder—Methotrexate—colon cancer	0.000983	0.00121	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Methotrexate—colon cancer	0.000981	0.00121	CcSEcCtD
Dexrazoxane—Skin disorder—Methotrexate—colon cancer	0.000973	0.0012	CcSEcCtD
Dexrazoxane—Asthenia—Capecitabine—colon cancer	0.000966	0.00119	CcSEcCtD
Dexrazoxane—Anorexia—Methotrexate—colon cancer	0.000955	0.00117	CcSEcCtD
Dexrazoxane—Pruritus—Capecitabine—colon cancer	0.000952	0.00117	CcSEcCtD
Dexrazoxane—Diarrhoea—Capecitabine—colon cancer	0.000921	0.00113	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000913	0.00112	CcSEcCtD
Dexrazoxane—Insomnia—Methotrexate—colon cancer	0.000906	0.00111	CcSEcCtD
Dexrazoxane—Dyspnoea—Methotrexate—colon cancer	0.000893	0.0011	CcSEcCtD
Dexrazoxane—Somnolence—Methotrexate—colon cancer	0.000891	0.00109	CcSEcCtD
Dexrazoxane—Dizziness—Capecitabine—colon cancer	0.00089	0.00109	CcSEcCtD
Dexrazoxane—Decreased appetite—Methotrexate—colon cancer	0.000871	0.00107	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Methotrexate—colon cancer	0.000865	0.00106	CcSEcCtD
Dexrazoxane—Fatigue—Methotrexate—colon cancer	0.000864	0.00106	CcSEcCtD
Dexrazoxane—Pain—Methotrexate—colon cancer	0.000857	0.00105	CcSEcCtD
Dexrazoxane—Vomiting—Capecitabine—colon cancer	0.000856	0.00105	CcSEcCtD
Dexrazoxane—Headache—Capecitabine—colon cancer	0.000843	0.00104	CcSEcCtD
Dexrazoxane—Feeling abnormal—Methotrexate—colon cancer	0.000826	0.00101	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Methotrexate—colon cancer	0.000819	0.00101	CcSEcCtD
Dexrazoxane—Nausea—Capecitabine—colon cancer	0.0008	0.000983	CcSEcCtD
Dexrazoxane—Urticaria—Methotrexate—colon cancer	0.000796	0.000978	CcSEcCtD
Dexrazoxane—Abdominal pain—Methotrexate—colon cancer	0.000792	0.000974	CcSEcCtD
Dexrazoxane—Body temperature increased—Methotrexate—colon cancer	0.000792	0.000974	CcSEcCtD
Dexrazoxane—Asthenia—Methotrexate—colon cancer	0.000719	0.000884	CcSEcCtD
Dexrazoxane—Pruritus—Methotrexate—colon cancer	0.000709	0.000871	CcSEcCtD
Dexrazoxane—Diarrhoea—Methotrexate—colon cancer	0.000686	0.000843	CcSEcCtD
Dexrazoxane—Dizziness—Methotrexate—colon cancer	0.000663	0.000814	CcSEcCtD
Dexrazoxane—Vomiting—Methotrexate—colon cancer	0.000637	0.000783	CcSEcCtD
Dexrazoxane—Headache—Methotrexate—colon cancer	0.000628	0.000772	CcSEcCtD
Dexrazoxane—Nausea—Methotrexate—colon cancer	0.000595	0.000732	CcSEcCtD
